Kajian klinikal Glioma di Alabama
6 kajian untuk Glioma sedang mencari peserta di lokasi di Alabama.
Bandar di Alabama
Teks kajian rasmi (Bahasa Inggeris)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Children's Hospital of Alabama, Birmingham
Mengambil pesertaFasa 1/2
12 Months – 21 Years · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07326566HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
Mengambil pesertaFasa 1
36 Months – 22 Years · Semua jantina · Dikemas kini 4 Sep 2026 · NCT03911388SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Alabama, Birmingham
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT05303519Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma
- UAB, Birmingham
- UAB, Birmingham
Mengambil pesertaFasa awal 1
Umur 10 hingga 89 · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT05632562Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- University of Alabama at Birmingham, Children's of Alabama, Birmingham
Mengambil pesertaFasa 1
Umur 1 hingga 25 · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT04485559Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.